Tango Therapeutics, Inc.

NasdaqGM:TNGX Stock Report

Market Cap: US$4.5b

Tango Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:TNGX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Feb 26SellUS$18,844,966Third Rock Ventures, LLCCompany1,500,000US$12.59
03 Feb 26SellUS$226,300Adam CrystalIndividual18,452US$12.90
03 Feb 26SellUS$374,294Barbara WeberIndividual30,519US$12.90
03 Feb 26SellUS$126,531Daniella BeckmanIndividual10,317US$12.90
19 Nov 25SellUS$12,354,149Third Rock Ventures, LLCCompany1,500,000US$8.27
12 Nov 25SellUS$32,542,609Third Rock Ventures, LLCCompany4,012,000US$8.20
23 Oct 25SellUS$4,846,575Third Rock Ventures, LLCCompany477,401US$10.15
25 Sep 25SellUS$4,008,500Third Rock Ventures, LLCCompany500,000US$8.02
16 Sep 25SellUS$2,559,329Third Rock Ventures, LLCCompany363,541US$7.04
08 Sep 25SellUS$5,108,970Third Rock Ventures, LLCCompany729,365US$7.04
22 Aug 25SellUS$2,115,358Third Rock Ventures, LLCCompany302,194US$7.00
19 Aug 25SellUS$7,712,760Third Rock Ventures, LLCCompany1,100,000US$7.01

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TNGX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies326,8860.178%
Individual Insiders1,774,4680.964%
VC/PE Firms18,863,81810.2%
Hedge Funds54,083,74829.4%
Institutions109,005,42159.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 33.4%.

Top Shareholders

Top 25 shareholders own 105.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.2%
RTW Investments, LP
13,300,620US$411.4m792%2.71%
8.86%
Adage Capital Management, L.P.
12,809,485US$396.2m20.8%0.36%
8.02%
TCG Crossover Management, LLC
11,597,737US$358.7m-9.12%6.76%
7.52%
Boxer Capital Management, LLC
10,876,219US$336.4m0%29.76%
6.85%
FMR LLC
9,905,918US$306.4m245%0.01%
6.29%
Farallon Capital Management, L.L.C.
9,097,411US$281.4m-30.4%0.99%
6.05%
BlackRock, Inc.
8,748,045US$270.6m2.43%no data
5.53%
Woodline Partners LP
8,000,013US$247.4m-20.6%0.56%
5.02%
Nextech Invest Ltd.
7,266,081US$224.7m0%8.63%
4.54%
Third Rock Ventures, LLC
6,568,748US$203.2m-18.6%15.0%
3.91%
Artal Group S.A.
5,657,105US$175.0m-30.7%2.2%
3.57%
Vanguard Capital Management, LLC
5,161,431US$159.6m0%no data
3.37%
The Goldman Sachs Group, Inc.
4,877,740US$150.9m1.2%0.03%
3.22%
State Street Global Advisors, Inc.
4,651,894US$143.9m-25.2%no data
2.87%
Deerfield Management Company, L.P.
4,146,813US$128.3m42.7%1.13%
2.77%
Paradigm Biocapital Advisors LP
4,009,679US$124.0m0%1.94%
2.72%
Holocene Advisors, LP
3,932,603US$121.6m0%0.18%
2.65%
Balyasny Asset Management L.P.
3,826,659US$118.4m-27.5%0.15%
2.07%
Logos Global Management, L.P.
3,000,000US$92.8m-28.6%3.36%
1.9%
Deep Track Capital, LP
2,750,000US$85.1m12%1.02%
1.85%
Geode Capital Management, LLC
2,675,777US$82.8m4.78%no data
1.67%
Caligan Partners, LP
2,408,798US$74.5m-35.4%2.99%
1.66%
Bellevue Asset Management AG
2,400,000US$74.2m-38.9%0.96%
1.66%
Janus Henderson Group plc
2,394,972US$74.1m-9.43%0.02%
1.49%
Vivo Capital, LLC
2,154,780US$66.6m0%4.17%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/09 13:08
End of Day Share Price 2026/06/09 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tango Therapeutics, Inc. is covered by 14 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yuan ZhiB. Riley Securities, Inc.
John NewmanCanaccord Genuity
Eric SchmidtCantor Fitzgerald & Co.